Evidence map›Paper›PMID 39688855›Full record

ArticleG3 (Bethesda, Md.)2025

Automated plasmid design for marker-free genome editing in budding yeast.

Lazar Stojković, Vojislav Gligorovski, Mahsa Geramimanesh, Marco Labagnara, Sahand Jamal Rahi

Abstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Development of a CRISPR/Cas12a genome editing toolbox inSynthetic and systems biotechnology · 2026
    Article
  2. Review
  3. Review
  4. Minimal shuttle vectors forSynthetic biology (Oxford, England) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lazar StojkovićLaboratory of the Physics of Biological Systems, Institute of Physics, École polytechnique fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland.
Vojislav GligorovskiLaboratory of the Physics of Biological Systems, Institute of Physics, École polytechnique fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland.ORCID 0000-0002-1804-8913
Mahsa GeramimaneshLaboratory of the Physics of Biological Systems, Institute of Physics, École polytechnique fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland.
Marco LabagnaraLaboratory of the Physics of Biological Systems, Institute of Physics, École polytechnique fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland.
Sahand Jamal RahiLaboratory of the Physics of Biological Systems, Institute of Physics, École polytechnique fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland.ORCID 0000-0001-6442-7087

Funding

SNSF CRSK-3_190526
6 · The paper itself

Abstract

Scarless genome editing in budding yeast with elimination of the selection marker has many advantages. Some markers such as URA3 and TRP1 can be recycled through counterselection. This permits seamless genome modification with pop-in/pop-out, in which a DNA construct first integrates in the genome and, subsequently, homologous regions recombine and excise undesired sequences. Popular approaches for creating such constructs use oligonucleotides and PCR. However, the use of oligonucleotides has many practical disadvantages. With the rapid reduction in price, synthesizing custom DNA sequences in specific plasmid backbones has become an appealing alternative. For designing plasmids for seamless pop-in/pop-out gene tagging or deletion, there are a number of factors to consider. To create only the shortest DNA sequences necessary, avoid errors in manual design, specify the amount of homology desired, and customize restriction sites, we created the computational tool PIPOline. Using it, we tested the ratios of homology that improve pop-out efficiency when targeting the genes HTB2 or WHI5. We supply optimal pop-in/pop-out plasmid sequences for tagging or deleting almost all S288C budding yeast open reading frames. Finally, we demonstrate how the histone variant Htb2 marked with a red fluorescent protein can be used as a cell-cycle stage marker, alternative to superfolder GFP, reducing light toxicity. We expect PIPOline to streamline genome editing in budding yeast.

Indexed as

Gene EditingGenome, FungalPlasmidsSaccharomyces cerevisiaeSaccharomycetalesSaccharomyces cerevisiae ProteinsSaccharomyces cerevisiae Proteinsbudding yeastgenomic editingmarker-freepop-in/pop-outscarless

Identifiers

PMID39688855
PMCPMC11917472

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.